Follow
Ioannis D. Karantas
Ioannis D. Karantas
“Apostolos Loukas” Medical Centre, Nicosia, Cyprus
Verified email at apostolosloukas.org
Title
Cited by
Cited by
Year
Recent trends on wound management: New therapeutic choices based on polymeric carriers
ME Okur, ID Karantas, Z Şenyiğit, NÜ Okur, PI Siafaka
Asian Journal of Pharmaceutical Sciences 15 (6), 661-684, 2020
2472020
Porous dressings of modified chitosan with poly (2-hydroxyethyl acrylate) for topical wound delivery of levofloxacin
PI Siafaka, AP Zisi, MK Exindari, ID Karantas, DN Bikiaris
Carbohydrate polymers 143, 90-99, 2016
1392016
Current update on nanoplatforms as therapeutic and diagnostic tools: a review for the materials used as nanotheranostics and imaging modalities
PI Siafaka, N Üstündağ Okur, ID Karantas, ME Okur, E Atlıhan Gündoğdu
1142020
Diabetes mellitus: A review on pathophysiology, current status of oral medications and future perspectives
ME Okur, ID Karantas, PI Siafaka
University of Istanbul, 2017
1112017
Hypertension in 2017: Update in treatment and pharmaceutical innovations
ME Okur, ID Karantas, NU Okur, PI Siafaka
Current Pharmaceutical Design 23 (44), 6795-6814, 2017
142017
Dyslipidemia management in 2020: an update on diagnosis and therapeutic perspectives
ID Karantas, ME Okur, NÜ Okur, PI Siafaka
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2021
122021
An updated review for the diabetic wound healing systems
ME Okur, EÖ Bülbül, G Mutlu, K Eleftherıadou, ID Karantas, NÜ Okur, ...
Current Drug Targets 23 (4), 393-419, 2022
112022
Transdermal drug delivery systems and their potential in Alzheimer’s disease management
PI Siafaka, EÖ Bülbül, G Mutlu, ME Okur, ID Karantas, NÜ Okur
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2020
102020
Protein and gene delivery systems for neurodegenerative disorders: where do we stand today?
PI Siafaka, ME Okur, PD Erim, EŞ Çağlar, E Özgenç, E Gündoğdu, ...
Pharmaceutics 14 (11), 2425, 2022
92022
Detecting and targeting neurodegenerative disorders using electrospun nanofibrous matrices: current status and applications
PI Siafaka, E Özcan Bülbül, P Dilsiz, ID Karantas, ME Okur, ...
Journal of Drug Targeting 29 (5), 476-490, 2021
82021
Polymeric microparticles as alternative carriers for antidiabetic glibenclamide drug
PI Siafaka, EŞ Cağlar, K Papadopoulou, V Tsanaktsis, ID Karantas, ...
Pharmaceutical and Biomedical Research, 2019
72019
Delivering active molecules to the eye; the concept of electrospinning as potent tool for drug delivery systems
PI Siafaka, EO Bulbul, AN Miliotou, ID Karantas, ME Okur, NÜ Okur
Journal of Drug Delivery Science and Technology, 104565, 2023
62023
An Updated Review For Hyperuricemia and Gout Management; Special Focus on the Available Drug Delivery Systems and Clinical Trials
ID Karantas, AN Miliotou, PI Siafaka
Current Medicinal Chemistry, 2024
32024
The application of nanogels as efficient drug delivery platforms for dermal/transdermal delivery
PI Siafaka, E Özcan Bülbül, ME Okur, ID Karantas, N Üstündağ Okur
Gels 9 (9), 753, 2023
32023
Schizophrenia; a review on promising drug delivery systems
EÖ Bülbül, ID Karantas, ME Okur, PI Siafaka, NÜ Okur
Current Pharmaceutical Design 26 (31), 3871-3883, 2020
22020
Nano-based carriers for pulmonary drug delivery: A review on the available drug delivery applications and toxicity issues
PI Siafaka, EÖ Bülbül, AN Miliotou, ID Karantas, ME Okur, NÜ Okur
Journal of Drug Delivery Science and Technology, 105381, 2024
12024
Polymeric Microparticles as Alternative Carriers for Antidiabetic Glibenclamide Drug Pharmaceutical and Biomedical Research. 2019; 5 (4): 27-34
S Siafaka, E Şefik Cağlar, K Papadopoulou, V Tsanaktsis, I Karantas, ...
DOI: http://dx. doi. org/10.18502/pbr. v5i4 2394, 0
1
Phytochemical compounds loaded to nanocarriers as potential therapeutic substances for Alzheimer's Disease-Could they be effective?
DÇ Polat, AE Karadağ, REP Köprülü, ID Karantas, G Mutlu, EŞ Çağlar, ...
Current pharmaceutical design, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–18